EFH
MIST icon

Eaton Financial Holdings’s Milestone Pharmaceuticals MIST Stock Holding History

Eaton Financial Holdings’s Portfolio MIST Stock Details MIST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$13.7K Hold
10,250
– – ﹤0.01% 134
2026
Q1 		$12.2K Sell
10,250
-2,500
-20% -$4.38K ﹤0.01% 125
2025
Q4 		$25.8K Buy
+12,750
New +$27.5K 0.01% 133

Other funds holding MIST

PCM
Pavaki Capital Management Pueblo, Colorado $287M AUM
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
PBM
Propel Bio Management Los Angeles, California $191M AUM 102.42% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
SAM
Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
KCM
Kalehua Capital Management Dallas, Texas $174M AUM
LPC
Lion Point Capital New York $20.9M AUM 195.52% 1-Year Est. Return

Eaton Financial Holdings's MIST Position: Q2 2026 in Review

Eaton Financial Holdings held its Milestone Pharmaceuticals (MIST) position steady in Q2 2026 at 10,250 shares worth $13.7K. The position accounts for ﹤0.01% of the portfolio, ranked #134.

Eaton Financial Holdings first reported a position in MIST in Q4 2025 and has held it in 3 quarters since. The position peaked at $25.8K in Q4 2025. 78 funds tracked by Wall St. Rank hold MIST as of Q2 2026.

  • Eaton Financial Holdings held 10,250 shares of Milestone Pharmaceuticals worth $13.7K as of Q2 2026.
  • Eaton Financial Holdings left its Milestone Pharmaceuticals share count unchanged in Q2 2026.
  • Milestone Pharmaceuticals made up ﹤0.01% of Eaton Financial Holdings's portfolio in Q2 2026, its #134 holding.
  • Eaton Financial Holdings first reported a position in Milestone Pharmaceuticals in Q4 2025 and has held it in 3 quarters since.
  • Eaton Financial Holdings's Milestone Pharmaceuticals position peaked at $25.8K in Q4 2025.
  • 78 funds tracked by Wall St. Rank held Milestone Pharmaceuticals as of Q2 2026.

Based on Eaton Financial Holdings's 13F filing for Q2 2026, filed 5 Aug 2026.